Skip to main content

EARNEST PARTNERS LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 1102578 ATLANTA, GA

Position in CRL

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$167,560,635
-$29,577,270 QoQ
Shares Held
971,366
-1.7% QoQ
Ownership
2.02%
of shares outstanding
% of Portfolio
0.70%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority Sole 65.89143536010114.ToString("F0")% Shared 19.16476384802433.ToString("F0")% None 14.943800791874533.ToString("F0")%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Mar 31, 2026

EARNEST PARTNERS LLC holds $648,674,120 across 7 Diagnostics & Research names. CRL ranks #1 (25.8% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 CRL
Charles River Laboratories International, Inc.
This page
971,366 $167,560,635

All Filings in CRL

Export CSV
25 filing rows on record
Report Date Value (USD) Shares
2026-03-31 $167,560,635 971,366
2025-12-31 $197,137,905 988,259
2025-09-30 $157,512,037 1,006,724
2025-06-30 $151,465,534 998,257
2025-03-31 $151,213,445 1,004,607
2024-12-31 $181,305,628 982,154
2024-09-30 $193,310,100 981,419
2024-06-30 $207,506,717 1,004,486
2024-03-31 $242,164,542 893,761
2023-12-31 $210,246,595 889,368
2023-09-30 $157,936,950 805,883
2023-06-30 $160,671,788 764,194
2023-03-31 $115,116,513 570,392
2022-12-31 $104,283,889 478,586
2022-09-30 $91,177,440 463,300
2022-06-30 $37,497,814 175,248
2022-03-31 $50,322,323 177,210
2021-12-31 $66,996,382 177,813
2021-09-30 $77,132,149 186,910
2021-06-30 $77,894,054 210,570
2021-03-31 $63,777,381 220,051
2020-12-31 $66,489,994 266,109
2020-09-30 $62,820,626 277,415
2020-06-30 $57,231,259 328,255
2020-03-31 $41,364,948 327,747